4SC AG INH. O.N./ DE000A3E5C40 /
2024-05-23 12:39:22 PM | Chg. +0.060 | Volume | Bid12:39:22 PM | Ask12:39:22 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
7.940EUR | +0.76% | - Turnover: - |
7.940Bid Size: - | 8.240Ask Size: - | 80.51 mill.EUR | 0.00% | - |
GlobeNewswire
2023-12-05
Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronch...
GlobeNewswire
2019-04-01
Dynavax’s SD-101 and 4SC’s Domatinostat Demonstrate Synergy and Induce a Systemic Anti-tumor Respons...
GlobeNewswire
2018-06-11
Global Pharma and Biotech Discovery Stage Partnering Terms and Agreements Directory 2012-2018